Monte Rosa Therapeutics, Inc. (GLUE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.24
Day's range
$18.43

Monte Rosa Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 05/15/2026 7.69 M $126.54 M   0.00% 11.74%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 6.72 M $110.55 M   31.28% 10.25%
BLACKROCK, INC. 05/13/2026 5.64 M $92.74 M   34.84% 8.60%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 4.62 M $76.03 M   0.00% 7.05%
BVF INC/IL 05/15/2026 4.46 M $73.38 M   16.29% 6.81%
BAKER BROS. ADVISORS LP 05/15/2026 4.35 M $71.49 M   0.00% 6.63%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 4.23 M $69.53 M   25.80% 6.45%
VESTAL POINT CAPITAL, LP 05/15/2026 3.60 M $59.28 M   364.96% 5.50%
STATE STREET CORP 05/15/2026 3.35 M $55.17 M   59.15% 5.12%
BRAIDWELL LP 05/15/2026 3.21 M $52.75 M   238.13% 4.89%
VERSANT VENTURE MANAGEMENT, LLC 05/05/2026 3.18 M $52.32 M   -27.42% 4.85%
05/15/2026 3.10 M $51.00 M   100.00% 4.73%
AMERICAN CENTURY COMPANIES INC 05/15/2026 2.81 M $46.22 M   111.31% 4.29%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 2.00 M $32.93 M   94.55% 3.05%
AISLING CAPITAL MANAGEMENT LP 05/05/2026 1.56 M $25.59 M   5.66% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.54 M $25.35 M   27.88% 2.35%
MARSHALL WACE, LLP 05/15/2026 1.43 M $23.58 M   259.29% 2.19%
BELLEVUE GROUP AG 05/15/2026 1.25 M $20.56 M   100.00% 1.91%
BIOIMPACT CAPITAL LLC 05/15/2026 1.18 M $19.36 M   0.30% 1.80%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.04 M $17.12 M   83.22% 1.59%
FMR LLC 05/15/2026 1.02 M $16.85 M   -21.21% 1.56%
GOLDMAN SACHS GROUP INC 05/15/2026 1.00 M $16.48 M   238.49% 1.53%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 1.00 M $16.45 M   100.00% 1.53%
NORTHERN TRUST CORP 05/14/2026 826.62 K $13.60 M   18.59% 1.26%
JANUS HENDERSON GROUP PLC 05/18/2026 685.93 K $11.29 M   100.00% 1.05%
ALPHABET INC. 05/08/2026 684.28 K $11.26 M   -8.14% 1.04%
MORGAN STANLEY 05/15/2026 684.06 K $11.25 M   -15.08% 1.04%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 658.48 K $10.83 M   -16.12% 1.00%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 651.99 K $10.73 M   1,024.30% 0.99%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 647.74 K $10.66 M   110.54% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 546.69 K $8.99 M   21.83% 0.83%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 528.70 K $8.70 M   1.02% 0.81%
05/08/2026 515.97 K $8.49 M   100.00% 0.79%
PARKWOOD LLC 05/15/2026 505.00 K $8.31 M   -28.67% 0.77%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 407.08 K $6.70 M   100.00% 0.62%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 400.00 K $6.58 M   100.00% 0.61%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 05/05/2026 392.23 K $6.45 M   1,355.12% 0.60%
BANK OF AMERICA CORP /DE/ 05/18/2026 387.54 K $6.38 M   73.34% 0.59%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 379.10 K $6.24 M   100.00% 0.58%
FISHER ASSET MANAGEMENT, LLC 05/05/2026 314.86 K $5.18 M   100.00% 0.48%
EMPOWERED FUNDS, LLC 06/16/2026 305.40 K $5.02 M   9.83% 0.47%
NEXTECH INVEST, LTD. 05/15/2026 304.24 K $5.00 M   8.95% 0.46%
TD ASSET MANAGEMENT INC 05/11/2026 286.98 K $4.72 M   34.44% 0.44%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 256.73 K $4.22 M   100.00% 0.39%
CITADEL ADVISORS LLC 05/15/2026 254.52 K $4.19 M   450.15% 0.39%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 250.00 K $4.11 M   100.00% 0.38%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 215.75 K $3.55 M   0.00% 0.33%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 209.80 K $3.45 M   55.78% 0.32%
BANK OF NEW YORK MELLON CORP 05/05/2026 204.69 K $3.37 M   18.11% 0.31%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 200.00 K $3.29 M   0.00% 0.31%

Monte Rosa Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 213 institutional investors and hedge funds held shares of Monte Rosa Therapeutics Inc. The most heavily invested institutionals were:

NEA Management Company, LLC: 7.69 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.72 M

BlackRock, Inc.: 5.64 M

TCG Crossover Management, LLC: 4.62 M

BVF INC/IL: 4.46 M

BAKER BROS. ADVISORS LP: 4.35 M

104.66% of Monte Rosa Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 88.93 M shares in the last 24 months. This purchase volume represents approximately $1.57 B in transactions.